Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariane Herson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Human Genetics : EJHG|September 13, 2018
Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parentAdeline Bonnard, Ariane Herson, Marcela Gargiulo, et al.
Journal of Medical Genetics|January 15, 2017
A liminal stage after predictive testing for Huntington diseaseMarcela Gargiulo, Sophie Tezenas du Montcel, Marie France Jutras, et al.
Journal of Inherited Metabolic Disease|November 13, 2014
Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven casesClaire-Cécile Michon, Marcela Gargiulo, Valérie Hahn-Barma, et al.
European Journal of Human Genetics : EJHG|December 10, 2020
Informing about genetic risk in families with Huntington disease: comparison of attitudes across two decadesLucie Pierron, Juliette Hennessy, Sophie Tezenas du Montcel, et al.
Neurology. Genetics|December 30, 2020
Who and Why? Requests for Presymptomatic Genetic Testing for Amyotrophic Lateral Sclerosis/Frontotemporal Dementia vs Huntington DiseaseMaria Del Mar Amador, Marcela Gargiulo, Christilla Boucher, et al.
Journal of Medical Genetics|October 21, 2022
Reproductive choices and intrafamilial communication in neurogenetic diseases with different self-estimated severitiesLucie Pierron, Sophie Tezenas du Montcel, Anna Heinzmann, et al.
Brain : a Journal of Neurology|January 14, 2012
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2CSerge Herson, Faycal Hentati, Aude Rigolet, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Human Genetics : EJHG|September 13, 2018
Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parentAdeline Bonnard, Ariane Herson, Marcela Gargiulo, et al.
Journal of Medical Genetics|January 15, 2017
A liminal stage after predictive testing for Huntington diseaseMarcela Gargiulo, Sophie Tezenas du Montcel, Marie France Jutras, et al.
Journal of Inherited Metabolic Disease|November 13, 2014
Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven casesClaire-Cécile Michon, Marcela Gargiulo, Valérie Hahn-Barma, et al.
European Journal of Human Genetics : EJHG|December 10, 2020
Informing about genetic risk in families with Huntington disease: comparison of attitudes across two decadesLucie Pierron, Juliette Hennessy, Sophie Tezenas du Montcel, et al.
Neurology. Genetics|December 30, 2020
Who and Why? Requests for Presymptomatic Genetic Testing for Amyotrophic Lateral Sclerosis/Frontotemporal Dementia vs Huntington DiseaseMaria Del Mar Amador, Marcela Gargiulo, Christilla Boucher, et al.
Journal of Medical Genetics|October 21, 2022
Reproductive choices and intrafamilial communication in neurogenetic diseases with different self-estimated severitiesLucie Pierron, Sophie Tezenas du Montcel, Anna Heinzmann, et al.
Brain : a Journal of Neurology|January 14, 2012
A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2CSerge Herson, Faycal Hentati, Aude Rigolet, et al.
Pageof 1